Food and Drugs Act
Marginal note:Clinical trials and investigational tests
21.71 The holder of a therapeutic product authorization referred to in paragraph 30(1.2)(c) shall ensure that prescribed information concerning the clinical trial or investigational test is made public within the prescribed time and in the prescribed manner.
- 2014, c. 24, s. 3
- 2019, c. 29, s. 168(F)
- Date modified: